These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10887274)

  • 21. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 22. Statins and the reduction of sudden cardiac death: antiarrhythmic or anti-ischemic effect?
    Beri A; Contractor T; Khasnis A; Thakur R
    Am J Cardiovasc Drugs; 2010; 10(3):155-64. PubMed ID: 20524717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term management of the survivor of ventricular fibrillation or sustained ventricular tachycardia.
    Connolly SJ; Krahn A; Klein G
    Can J Cardiol; 2000 Jun; 16 Suppl C():20C-2C. PubMed ID: 10887273
    [No Abstract]   [Full Text] [Related]  

  • 24. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators.
    Buxton AE; Sweeney MO; Wathen MS; Josephson ME; Otterness MF; Hogan-Miller E; Stark AJ; Degroot PJ;
    J Am Coll Cardiol; 2005 Jul; 46(2):310-6. PubMed ID: 16022960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
    Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
    Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy.
    Marrouche NF; Verma A; Wazni O; Schweikert R; Martin DO; Saliba W; Kilicaslan F; Cummings J; Burkhardt JD; Bhargava M; Bash D; Brachmann J; Guenther J; Hao S; Beheiry S; Rossillo A; Raviele A; Themistoclakis S; Natale A
    J Am Coll Cardiol; 2004 May; 43(9):1715-20. PubMed ID: 15120835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progress in antiarrhythmic therapy].
    Yamashita T
    Nihon Rinsho; 2009 Sep; 67(9):1811-20. PubMed ID: 19768921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable cardioverter-defibrillators: not the ultimate gold standard for gauging therapy of VT/fibrillation.
    Singh BN
    Am J Cardiol; 1994 Jun; 73(16):1211-3. PubMed ID: 8203341
    [No Abstract]   [Full Text] [Related]  

  • 29. Preventing sudden cardiac death.
    Calkins H
    Health News; 2000 Jan; 6(1):3. PubMed ID: 11019657
    [No Abstract]   [Full Text] [Related]  

  • 30. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiofrequency catheter ablation for ventricular tachycardia.
    Haqqani HM; Roberts-Thomson KC
    Heart Lung Circ; 2012 Jun; 21(6-7):402-12. PubMed ID: 22237136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
    Singh S; Murawski MM
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post automatic implantable cardioverter defibrillator implant therapies: drugs and ablative techniques.
    Colella A; Pieragnoli P; Ricciardi G; Giaccardi M; Padeletti L; Michelucci A
    Minerva Cardioangiol; 2007 Jun; 55(3):341-51. PubMed ID: 17534253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists.
    Stevenson WG; Chaitman BR; Ellenbogen KA; Epstein AE; Gross WL; Hayes DL; Strickberger SA; Sweeney MO; ;
    Circulation; 2004 Dec; 110(25):3866-9. PubMed ID: 15611390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary prevention of sudden death.
    Cappato R; Kuck KH
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():39-44. PubMed ID: 10590487
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ventricular arrhythmias : What has been confirmed in therapy?].
    Duncker D; Bauersachs J; Veltmann C
    Internist (Berl); 2017 Dec; 58(12):1272-1280. PubMed ID: 29071387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implantable defibrillator therapy.
    Alings AM
    Neth J Med; 2003 May; 61(5 Suppl):4-7. PubMed ID: 12918543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.